Christopher Wall, Chief Medical Officer at PrairieCare, delves into our "Treatment to Remission" philosophy
You're on GLP-1s or want to track what's working Adding a blend to a protocol with Retatrutide, Tirzepatide, or other active compounds makes it hard to attribute effects
The focus is on expanding access to GLP-1 therapy, improving convenience through differentiated delivery systems, and supporting long-term metabolic care
Inject subcutaneously 1-2 inches from the wound edge rather than directly into damaged tissue
Regulatory Status: A Rapidly Changing Landscape This is the part of the conversation that directly affects anyone considering peptide therapy and that requires the most current, accurate information
It also has a chemical attachment that helps it stay in the bloodstream longer